Evaluating the Use of the Qidni/D Hemodialysis System by Subjects With End-Stage Renal Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-05-01

Study Completion Date

2024-07-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main goal of this clinical study is to evaluate the safety of the Qidni/D Hemodialysis System in patients with end-stage renal disease. The main question it aims to answer is:

Is the Qidni/D safe for performing hemodialysis?

Participants will be subjected to one treatment of hemodialysis for up to 4 hours with the use of the Qidni/D.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Safety and Efficacy Assessments of NeoKidney® in ESRD Patients Treated With Short Daily Hemodialysis

NCT06024135

End Stage Renal Disease ESRD

UNKNOWN NA

Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™

NCT00667511

Kidney Failure, Chronic End-Stage Renal Disease

COMPLETED NA

Conventional Hemodialysis vs. Short Daily Hemodialysis (6 Days / Week) and Mechanisms of Blood Pressure Control

NCT00759967

End Stage Renal Disease

COMPLETED NA

Effect of Renal Denervation on Bood Pressure in Patients on Hemodialysis

NCT06556407

Treatment Resistant Hypertension Chronic Hemodialysis

RECRUITING NA

Comparing Hemodiafiltration with and Without Hemoadsorption

NCT06710834

Hemodialysis Hemodiafiltration Hemoadsorption

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Kidney Disease, End-Stage

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Prospective, single-center, non-randomized study. All participants are enrolled into a single group to be treated with the experimental device.

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental Treatment Arm

Patients will receive one treatment of hemodialysis through the Qidni/D Hemodialysis System.

Group Type EXPERIMENTAL

Qidni/D Hemodialysis System

Intervention Type DEVICE

Qidni/D is a hemodialysis device for patients with end-stage renal disease.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Qidni/D Hemodialysis System

Qidni/D is a hemodialysis device for patients with end-stage renal disease.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject has provided informed consent.
* Subject is at least 18 years and less than 75 years of age.
* Subject has end-stage renal disease adequately treated by maintenance dialysis and has been deemed stable for at least three months by his/her treating nephrologist.
* Subject has a well-functioning and stable vascular access that allows a blood flow of at least 300 ml/min for conventional treatment or 200-250 mL/min for nocturnal hemodialysis treatment.
* Subject understands the nature of the procedures and the requirements of the study protocol.
* Subject is willing and able to comply with the protocol requirements and return to the treatment center for all required treatments and clinical evaluations.
* Subject has no childbearing potential or the Subject affirms they are not pregnant. Subject affirms using contraception measures to prevent potential pregnancies during the study period.

Exclusion Criteria

* Subject is unable to read English.
* Subject has dementia or lacks capacity for self-care.
* Life expectancy less than 12 months from first study procedure.
* Subject unable to understand or cooperate with the hemodialysis nurse and dialysis care team.
* Subject has a documented history of non-adherence to dialysis therapy that would prevent successful completion of the study.
* Subject has had a recent major cardiovascular adverse event within the last 3 months.
* Subject has a persistent pre-dialysis sitting systolic blood pressure less than 100 mmHg despite medical therapy.
* Subject has ongoing, symptomatic intra-dialytic hypotension requiring medical intervention.
* Subject has an active infection requiring antibiotics within the last 7 days.
* Subject with fluid overload due to intractable ascites secondary to liver cirrhosis.
* Subject is seroreactive for Hepatitis B Surface Antigen.
* Subject has a history of adverse reactions to dialyzer membrane material.
* Subject is participating in another investigative drug or device clinical study related to dialysis which conflicts with the execution of this study.
* Subject is scheduled to receive an organ transplant during the course of the study: paired exchange or living donor.
* Subject has a life-threatening malignancy actively receiving treatment that would prevent successful completion of the study protocol.
* Any other documented condition that the Investigator feels would prevent the Subject from successful inclusion in the study.
* Subject has an active viral infection (eg. COVID-19).
* Subject is on peritoneal dialysis.

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No